170348 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa Plasmodium
PREVENTING AND TREATING MALARIA
#2NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE
#3METHODS AND REAGENTS FOR DETECTING PIPERAQUINE-RESISTANT PLASMODIUM FALCIPARUM MALARIA
#4System, method, apparatus and diagnostic test for plasmodium vivax
#5INFECTED CELL CULTURES
#6AUTOMATIC DEVICE FOR NON-INVASIVE MALARIA DIAGNOSIS THROUGH OPTICAL REFLECTANCE TECHNIQUES, METHODS AND USES THEREOF
#7BIOSENSOR FOR ELECTROCHEMICAL DETECTION OF E.G. MALARIA BIOMARKERS
#8SAMPLE ANALYSIS METHOD, SAMPLE ANALYZER, AND COMPUTER-READABLE STORAGE MEDIUM
#9PLASMODIUM VIVAX MALE GAMETE FUSION PROTEIN PVHAP2 AND THE PUTATIVE PROLIFERATING-CELL NUCLEOLAR ANTIGEN P120 AS RELAPSE BIOMARKERS
#10Neutralizing antibodies to circumsporozoite protein and their use
#11PREVENTING AND TREATING MALARIA
#12A Spectral Imaging Platform For Infectious Disease Diagnosis
#13Anti-plasmodium falciparum HRP-II antibody
#14Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine
#15MALARIA SPECIES DETECTION
#16ISOLATION OF CIRCULATING CELLS OF FETAL ORIGIN USING RECOMBINANT MALARIA PROTEIN VAR2CSA
#17Malaria detection method and device
#18Molecular marker of plasmodium falciparum artemisinin resistance
#19System, method, apparatus and diagnostic test for
#20Infected Cell Cultures
#21Malaria species detection
#22Diagnostics systems and methods
#23and vaccine
#24SYSTEM, METHOD, APPARATUS AND DIAGNOSTIC TEST FOR PREGNANCY
#25Rapid test for the detecting pathogens and cells and method
#26PLASMODIUM FALCIPARUM AND PLASMODIUM VIVAX VACCINE
#27METHOD FOR DETECTING PRESENCE OF A THIOETHER AND KIT FOR DETECTING SAME
#28Methods for diagnosing infectious diseases using adsorption media
#29Blood analyzer and blood analyzing method for determining if plasmodium infection is present
#30Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine
#31Non-invasive method for detecting a deadly form of malaria
#32Compositions and methods for detection of malaria biomarkers
#33METABOLIC RESTRICTION IN CELL-BASED ASSAYS
#34Methods and reagents for detecting piperaquine-resistant plasmodium falciparum malaria
#35Method and system for detection of disease agents in blood
#36Anti-malarial antibodies that bind circumsporozoite protein
#37SEROLOGY ASSAY FOR RECENT MALARIA INFECTION
#38Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines
#39PROTEINS COMPRISING A MUTATED LAIR-1 FRAGMENT AND USES THEREOF
#40Lateral flow assays with thermal contrast readers
#41Diagnostics systems and methods
#42BIOMARKERS FOR MALARIA DIAGNOSIS
#43Blood based Plasmodium infection analyzer
#44Malaria detection
#45Aggregation-assisted separation of plasma from whole blood
#46Method and system for detection of disease agents in blood
#47Artificial antigen produced using partial sequence of enolase protein originated from plasmodium falciparum, and method for producing same
#48INHIBITORS OF MALARIAL AND HUMAN GLUCOSE TRANSPORTERS AND METHODS FOR IDENTIFYING THE INHIBITORS
#49METHODS AND COMPOSITIONS FOR ANALYZING GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACTIVITY IN BLOOD SAMPLES
#50INTEGRATION OF SAMPLE SEPARATION WITH RAPID DIAGNOSTIC TESTS FOR IMPROVED SENSITIVITY
#51METHOD FOR DETECTING A PLASMODIUM INFECTION
#52Multi-component-multistage malaria vaccines
#53Methods for diagnosing infectious diseases using adsorption media
#54Blood analyzing method as well as stain solution and blood analyzer used for the same
#55Blood analyzer and blood analyzing method
#56Methods of detecting plasmodium infection
#57PAPER-BASED IMMUNOASSAY WITH POLYMERIZATION-BASED SIGNAL AMPLIFICATION
#58Methods and compositions for expressing functional class XIV myosin
#59Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction
#60Molecular marker of plasmodium falciparum artemisinin resistance
#61Combination therapies for malaria
#62Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis
#63Methods for diagnosing infectious diseases using adsorption media
#64Blood analyzing device for malaria analysis
#65Methods and devices for integrating analyte extraction, concentration and detection
#66BIOMARKER
#67Method of screening anti-plasmodial activity of acriflavin and acriflavin as an anti-malarial agent
#68Recombinant polypeptide construct comprising circumsporozoite protein HLA class I restricted T-cell epitopes
#69Use of a cysteine protease of plasmodium vivax
#70Systems, devices, and methods including a dark-field reflected-illumination apparatus
#71Method for evaluating the sensitivity and specificity of fast malaria-diagnosis test kits
#72Multi-fluorescent substance including novel coumarin derivative, and LED light source-based microfluorescent quantitative biosensor for diagnosis using same
#73Methods and apparatuses for identifying red blood cells infected by plasmodium
#74Systems, devices, and methods for detection of malaria
#75Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors
#76Method of neonatal serological diagnosis
#77Treatment and prevention of malaria
#78Method for detecting a plasmodium infection
#79Compositions and methods for treatment, research and therapeutic applications for malaria
#80Nucleic acid aptamers against plasmodium lactate dehydrogenase and histidine-rich protein II and uses thereof for malaria diagnosis
#81Mutant parasites for use as vaccines and platforms for screening for compounds
#82Compositions and methods for diagnosis, prognosis and management of malaria
#83Methods of diagnosing a plasmodium infection
#84Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
#85Microfluidic devices and methods for malaria detection
#86Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction
#87Nucleotide and amino acid sequences encoding an exported protein 1 derived from and uses thereof
#88Methods and compositions for treating and preventing malaria using an invasion ligand directed to a protease-resistant receptor
#89MSP2 ANTIGENIC PEPTIDES AND THEIR USE
#90METHOD FOR SCREENING COMPOUNDS FOR THEIR ABILITY TO INCREASE RIGIDITY OF RED BLOOD CELLS INFECTED BY A PROTOZOAN PARASITE OF THE GENUS PLASMODIUM, METHOD FOR FILTERING RED BLOOD CELLS, AND APPLICATION THEREOF
#91Systems, devices, and methods including a dark-field reflected-illumination apparatus
#92Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites
#93Systems, devices, and methods for detection of malaria
#94Systems, devices, and methods including a dark-field reflected-illumination apparatus
#95Systems, devices, and methods including multi-harmonic optical detection of hemozoin nanoparticles
#96Systems, devices, and methods including a dark-field reflected-illumination apparatus
#97Plasmodium falciparum HLA class I restricted T-cell epitopes
#98Compositions and methods for diagnosis, prognosis and management of malaria
#99Malaria detection by small angle light scattering
#100Use of a cysteine protease of Plasmodium vivax
#101Methods for detecting virulent , for evaluating virulence, and for screening new drugs employing the 3′ UTR of SUB2 and the SUB2 serine protease
#102ANGIOPOIETIN-1 AND -2 BIOMARKERS FOR INFECTIOUS DISEASES THAT COMPROMISE ENDOTHELIAL INTEGRITY
#103PSEUDOMONAS AERUGINOSA-OUTER MEMBRANE PROTEIN PA4710
#104Genetic markers associated with endometriosis and use thereof
#105Systems, devices, and methods including enhanced dark field detection of hemozoin nanoparticles
#106Systems, devices, and methods including paramagnetic oscillation, rotation and translation of hemozoin asymmetric nanoparticles in response to multi-harmonic optical detection of the presence of hemozoin
#107Nucleotide and amino acid sequences encoding an exported protein 1 derived from and uses thereof
#108Isolation and purification of merozoite protein-1vaccine
#109Systems, devices, and methods including paramagnetic oscillation, rotation and translation of hemozoin asymmetric nanoparticles in response to multi-harmonic optical detection of the presence of hemozoin
#110Systems, devices, and methods for inducing ultraviolet energy generation via hemozoin nanoparticles in a biological tissue
#111Systems, devices, and methods including paramagnetic oscillation, rotation, and translation of hemozoin asymmetric nanoparticles in response to dark-field or Rheinberg detection of the presence of hemozoin
#112Malaria antigen screening method
#113PLASMODIUM FALCIPARUM ANTIGENS INDUCING PROTECTIVE ANTIBODIES
#114Method, reagent and kit for malaria testing
#115Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
#116Recombinant merozoite protein-1vaccine
#117Methods and Kits for Detecting and Quantifying Damage Caused by a Parasite
#118Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases
#119Devices and methods for detecting β-haematin and haemozoin
#120and genes and uses thereof
#121Methods and compositions for treating and preventing malaria (2)
#122IMMUNOASSAY FOR PLASMODIUM FALCIPARUM AND ASSAY DEVICE USED THEREFOR
#123METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MALARIA
#124Compositions and methods for treatment, research and therapeutic applications for malaria
#125diagnostic assay device
#126Detection/Measurement Of Malaria Infection Disease Utilizing Natural Immunity By Hemozoin Induction, Screening Of Preventative Or Therapeutic Medicine For Malaria Infection Disease, And Regulation Of Natural Immunity Induction
#127Recombinant merozoite protein-1vaccine
#128Assay implementation in a microfluidic format
#129Novel therapeutic target for protozoal diseases
#130Plasmodium vivax blood stage antigens, PVESP-1, antibodies and diagnostic assays
#131Therapeutic target for protozoal diseases
#132Non-human mammal model comprising heterologous nucleated cells - use for screening compounds
#133Methods for detecting virulent , for evaluating virulence, and for screening new drugs employing the 3′UTR of SUB2 and the SUB2 serine protease
#134Method of screening
#135Process for producing antigenic substance
#136antigens inducing protective antibodies
#137Assay to screen for anti-malarials
#138Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites
#139Isolation and purification of merozoite protein-142 vaccine
#140Expression, purification and uses of a liver stage antigen 1 polypeptide
#141Novel "Cleave-N-Read" system for protease activity assay and methods of use thereof
#142Assay for detecting the presence of processing inhibitory antibodies against the Apical Membrane Antigen-1 of Plasmodium falciparum in biological samples
#143Apparatus and method for detecting paramagnetic and superparamagnetic biomarkers